New roles of glutamate receptors in glias and gliomas

Brain and Nerve

Volumn 61, Issue 7, 2009, Pages 753-764

  Ishiuchi, Shogo ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Calcium permeability; Glioblastoma; Glutamate receptor; Therapy

Indexed keywords

ADENOVIRUS VECTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM; GLUTAMIC ACID; TEMOZOLOMIDE;

APOPTOSIS; CELL MIGRATION; CELL PROLIFERATION; GENE; GLIA; GLIOBLASTOMA; GLIOMA; GLUR2 GENE; PURKINJE CELL; REVIEW; SYNAPSE;

ADENOSINE DEAMINASE; ANIMALS; BENZODIAZEPINES; BRAIN NEOPLASMS; CALCIUM; CEREBELLUM; EXCITATORY AMINO ACID ANTAGONISTS; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; NEUROGLIA; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RNA EDITING;

EID: 67849100773     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Müller T, Möller T, Berger T, Schnitzer J, Kettenmann H: Calcium entry through kainate receptors and resulting potassium-channel blockade in Bergmann glial cells. Science 256: 1563-1566, 1992
2. 2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8: 971-978, 2002 (Pubitemid 35033701)
3. Maas S, Patt S, Schrey M, Rich A: Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci USA 98: 14687-14692, 2001 (Pubitemid 33121452)
4. 2+-permeable AMPA receptor channels. Neuroreport 12: 745-748, 2001 (Pubitemid 32222710)
5. 2+-permeable AMPA receptors in Bergmann glia. Science 292: 926-929, 2001 (Pubitemid 32422489)
6. Yoshida Y, Tsuzuki K, Ishiuchi, S, Ozawa S: Serum- dependence AMPA receptor mediated proliferation in glioma cells. Pathol Int 56: 262-271, 2006
7. 2+-permwable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 27: 7987-8001, 2007 (Pubitemid 47173326)
8. Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, et al: Down-regulation of RNA editing in pediatric astrocytomas. ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem 283: 7251-7260, 2008
9. Ye ZC, Sontheimer H: Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59: 4383-4391, 1999
10. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, et al: Glutamate release promotes growth of malignant gliomas. Nat Med 7: 1010-1015, 2001 (Pubitemid 32937380)
11. Sontheimer H: Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage. Trends Neurosci 26: 543-549, 2003
12. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, et al: PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93: 1246-1256, 2001 (Pubitemid 32816199)
13. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA: Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 62: 3729-3735, 2002
14. Shawver LK, Salmon D, Ullrich A: Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1: 117-123, 2002
15. Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999
16. Alessi DR, Cohen P: Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 8: 55-62, 1998 (Pubitemid 28122141)
17. Osaki M, Oshimura M, Ito H: PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9: 667-676, 2004 (Pubitemid 40941196)
18. Cantley LC, Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 96: 4240-4245, 1999
19. Li J, Yen C, Liaw D, Podsypanina K, Bose S, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997
20. Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 273: 13375-13378, 1998 (Pubitemid 28268370)
21. Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, et al: Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63: 2742-2746, 2003 (Pubitemid 36667143)
22. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, et al: Negative regulation of PKB/Akt- dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998 (Pubitemid 28458022)
23. Toker A, Newton AC: Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 275: 8271-8274, 2000 (Pubitemid 30180163)
24. Vanhaesebroeck B, Alessi DR: The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346: 561-576, 2000 (Pubitemid 30171014)
25. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, et al: Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353: 2012-2024, 2005 (Pubitemid 41609094)
26. Kanegae Y, Takamori K, Sato Y, Lee G, Nakai M, et al: Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 181: 207-212, 1996 (Pubitemid 26418271)
27. Kohara A, Okada M, Tsutsumi R, Ohno K, Takahashi M, et al: In-vitro characterization of YM872, a selective, potent and highly water-soluble α-amino-3- hydroxy-5-methylisoxazole-4-propionate receptor antagonist. J Pharm Pharmacol 50: 795-801, 1998 (Pubitemid 28379275)
28. Yamashita H, Ohno K, Amada Y, Imai H, Shishikura J, et al: Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate- induced seizures in rats. Naunyn Schmiedebergs Arch Pharmacol 370: 99-105, 2004 (Pubitemid 39222861)
29. Langan YM, Lucas R, Jewell H, Toublanc N, Schaefer H et al :Talampanel, a new antiepileptic drug: single- and multi-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy. Epilepsia 44: 46-53, 2003 (Pubitemid 36733620)
30. 2+-permeable AMPA receptors in cultured rat hippocampal neurons. Neurosci Res 29: 27-36, 1997 (Pubitemid 27365675)
31. Grossman SA, Ye X, Chamberlain MC, Mikkelsen T, Batchelor TT, et al:Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM). J Clin Oncol 26: suppl; abstr 2014, 2008
32. Ikomonidou C, Turski L: Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1: 383-386, 2002
33. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J et al: Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74, 1999 (Pubitemid 29044848)